Vision Scientists and FDA Discuss Impact of Patient-Reported Outcomes on Product Labeling
Tuesday, December 7, 2010 - 16:00
in Health & Medicine
The vision community is discussing with the Food and Drug Administration (FDA) how vision-related patient-reported outcomes (PROs) might be used in improving the labeling of ophthalmic treatments and products. The group -- composed of researchers, clinicians, policymakers and representatives from industry and vision associations -- attended a one-day symposium sponsored by the National Institutes of Health's National Eye Institute (NEI) and the FDA on October 13, 2009.